ShareCompartir
Announcement: Expansion of VariZIG distribution in the United States
In July 2013, CDC published updated recommendations for the use of VariZIG for postexposure prophylaxis of varicella for persons at high risk for severe disease who lack evidence of immunity to varicella and for whom varicella vaccine is contraindicated (1). At the time of the recommendation, VariZIG was available from only one U.S. distributor (FFF Enterprises; Temecula, California; telephone, 800-843-7477; online at http://www.fffenterprises.com). Now, VariZIG is also available from a second distributor (ASD Healthcare; Frisco, Texas; telephone, 800-746-6273; online at http://www.asdhealthcare.com).
Reference
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
All MMWR HTML versions of articles are electronic conversions from typeset documents.
This conversion might result in character translation or format errors in the HTML version.
Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr)
and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S.
Government Printing Office (GPO), Washington, DC 20402-9371;
telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
